Experimental Oncology, 2015, № 4 http://dspace.nbuv.gov.ua:80/handle/123456789/133167 Sat, 18 Apr 2026 21:25:40 GMT 2026-04-18T21:25:40Z Experimental Oncology, 2015, № 4 http://dspace.nbuv.gov.ua:80/bitstream/id/395862/ http://dspace.nbuv.gov.ua:80/handle/123456789/133167 Acknowledgement http://dspace.nbuv.gov.ua:80/handle/123456789/145717 Acknowledgement Thu, 01 Jan 2015 00:00:00 GMT http://dspace.nbuv.gov.ua:80/handle/123456789/145717 2015-01-01T00:00:00Z Subject index to volume 37 (2015) http://dspace.nbuv.gov.ua:80/handle/123456789/145716 Subject index to volume 37 (2015) Thu, 01 Jan 2015 00:00:00 GMT http://dspace.nbuv.gov.ua:80/handle/123456789/145716 2015-01-01T00:00:00Z Authors index to volume 37 (2015) http://dspace.nbuv.gov.ua:80/handle/123456789/145715 Authors index to volume 37 (2015) Thu, 01 Jan 2015 00:00:00 GMT http://dspace.nbuv.gov.ua:80/handle/123456789/145715 2015-01-01T00:00:00Z Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy http://dspace.nbuv.gov.ua:80/handle/123456789/145561 Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy Lakota, J.; Gocarova, K.; Spanik, S. This is a clinical observation of a patient treated for metastatic head and neck cancer with mesenchymal stem cells mediated prodrug gene therapy. The cells were applied intravenously. We did not observe any therapeutic effect. However, a temporal bicytopenia was observed. Key Words: metastatic head and neck cancer, therapeutic stem cells, blood counts. Thu, 01 Jan 2015 00:00:00 GMT http://dspace.nbuv.gov.ua:80/handle/123456789/145561 2015-01-01T00:00:00Z